Antonio Della Croce graduated in Pharmaceutical Chemistry at the University of Milan, Italy and earned an Executive Master’s Degree in Pharmaceutical Administration from LUISS Business School in Rome.
He started his career in the pharmaceutical industry at Knoll, where he held sales and marketing roles in Milan (Italy) and Ludwigshafen (Germany). After the acquisition by Abbott, he moved to Rome where he managed various Business Units in different Therapeutic Areas: Cardiology , Anesthesia and Critical Care and Immunology.
After the inception of AbbVie as a split from Abbott, he moved to Global Marketing and Commercial Operation positions in Paris and Chicago, in the fields of Rheumatology, Dermatology and Oncology.
In 2020 he moved to Portugal as General Manager of the local AbbVie affiliate and since July 2023 he has been appointed in his current role of GM Czech Republic and Slovakia.